TLR4 and stroke disorder: Hu et al. [21, 30] reported that Senkyunolide I could alleviate stroke-induced neuroinflammation via suppressing the TLR4/NF-κB pathway and protect against cerebral reperfusion injury with its antiapoptosis properties.